Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Squamous Cell Carcinoma

Explore clinical trials studying Head and Neck Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

354 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Squamous Cell Carcinoma trial results

Completed

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

NCT04490564

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations
  • University General Hospital of Alexandroupoli Alexandroupoli, Alexandroupolis, Greece
  • Sotiria Thoracic Diseases Hospital of Athens Athens, Attica, Greece
  • Aretaieio University Hospital of Athens Athens, Attica, Greece
  • University General Hospital of Athens Attikon Athens, Attica, Greece
View Trial Details
Completed

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

NCT04045496

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
Locations
  • HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States
  • Tennessee Oncology, PLLC Nashville, Tennessee, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
  • Washington University School of Medicine Seattle, Washington, United States
View Trial Details
Completed

A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

NCT06273852

Conditions
Breast Diseases, Breast Neoplasms, Carcinoma, +13 more
Locations
  • LSU Health Sciences Center Shreveport, Louisiana, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Sarah Cannon Research Institute Charleston, South Carolina, United States
View Trial Details
Completed

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

NCT05585034

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +58 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View Trial Details
Completed

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

NCT04616196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +16 more
Locations
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details

Related conditions